10x Genomics, Inc. Deferred Revenue Recognized
10x Genomics, Inc. (TXG) reported Deferred Revenue Recognized of -$14.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-07
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $8.71M, a 1.84% decline year-over-year.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $4.13M, a 52.38% increase year-over-year.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $5.05M, a 60.39% increase year-over-year.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $8.88M, a 146.95% increase year-over-year.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $20.13M, a 76.47% increase from fiscal 2024.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $11.41M, a 73.15% increase from fiscal 2023.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $6.59M, a 37.45% increase from fiscal 2022.
- 10x Genomics, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $4.79M, a 16.87% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$14.50M 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | $8.71M 10-Q · filed 2026-05-08 | ||||||
| 2025-12-31 | $20.13M 10-K · filed 2026-02-13 | ||||||
| 2025-09-30 | $4.13M 10-Q · filed 2025-11-07 | $15.04M 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | $5.05M 10-Q · filed 2025-08-08 | -$11.11M 10-Q · filed 2026-08-07 | $10.90M 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | $8.88M 10-Q · filed 2026-05-08 | $5.86M 10-Q · filed 2025-05-09 | |||||
| 2024-12-31 | $11.41M 10-K · filed 2026-02-13 | ||||||
| 2024-09-30 | $2.71M 10-Q · filed 2025-11-07 | $9.45M 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | $3.15M 10-Q · filed 2025-08-08 | $6.74M 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | $3.60M 10-Q · filed 2025-05-09 | $6.93M 10-Q · filed 2024-04-30 | |||||
| 2023-12-31 | $6.59M 10-K · filed 2025-02-13 | ||||||
| 2023-09-30 | $1.53M 10-Q · filed 2024-10-29 | $5.50M 10-Q · filed 2024-10-29 | |||||
| 2023-06-30 | $1.86M 10-Q · filed 2024-08-08 | $3.96M 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | $2.11M 10-Q · filed 2024-04-30 | ||||||
| 2022-12-31 | $4.79M 10-K · filed 2024-02-15 | ||||||
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-03 | $3.94M 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | $1.29M 10-Q · filed 2023-08-04 | $1.30M 10-Q · filed 2022-08-09 | $2.90M 10-Q · filed 2023-08-04 | $1.10M 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $1.60M 10-Q · filed 2023-05-04 | $1.60M 10-Q · filed 2022-05-05 | |||||
| 2021-12-31 | $4.10M 10-K · filed 2023-02-16 | ||||||
| 2021-09-30 | $884.00K 10-Q · filed 2022-11-03 | $900.00K 10-Q · filed 2021-11-05 | $3.41M 10-Q · filed 2022-11-03 | $3.40M 10-Q · filed 2021-11-05 | |||
| 2021-06-30 | $2.90M 10-Q · filed 2022-08-09 | $1.10M 10-Q · filed 2021-08-06 | $2.50M 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | $1.40M 10-Q · filed 2021-05-07 | ||||||
| 2020-12-31 | $3.29M 10-K · filed 2022-02-18 | ||||||
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-05 | $2.80M 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-12 | $2.10M 10-Q · filed 2020-08-12 | |||||
| 2019-12-31 | $2.25M 10-K · filed 2021-02-26 |